Medicare Enrolled
Dr. Jeffrey Greski, DO
Urology Physician · Rochester Hills, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Greski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Greski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Greski
Dr. Jeffrey Greski is an urology physician in Rochester Hills, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Greski performed 1,874 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Greski received a total of $5,458 from 46 pharmaceutical and/or device companies across 277 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Greski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 29% volume in MI
$5,458 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,874
Medicare services
Top 29% in MI for urology physician
Not available
Unique patients (not deduplicated)
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
552 | $65 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
439 | $64 | $130 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
194 | $66 | $419 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
182 | $68 | $160 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
140 | $4 | $10 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
55 | $77 | $250 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
48 | $8 | $50 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
42 | $124 | $1,000 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $101 | $200 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
34 | $106 | $250 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
28 | $16 | $45 |
| Ureteral stone crushing with endoscope A procedure to break up a stone in the ureter using an endoscope. The endoscope is inserted to locate and crush the stone. |
27 | $331 | $1,000 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
16 | $107 | $550 |
| Cystourethroscopy with ureteroscopy or pyeloscopy A diagnostic procedure using an endoscope to examine the bladder, urethra, and ureter or kidney. |
15 | $246 | $700 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
15 | $27 | $250 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
15 | $26 | $350 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
14 | $106 | $350 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
12 | $585 | $2,000 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $118 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
3.1% high complexity
4.9% medium
92.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,458
Total received (2018-2024)
Avg $780/year across 7 years
Top 31% in MI for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
277
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$824
2023
$1,014
2022
$676
2021
$768
2020
$669
2019
$843
2018
$664
Payments by company (2024)
Sumitomo Pharma America, Inc.
$180
Dendreon Pharmaceuticals LLC
$80
180 Medical, Inc.
$77
Astellas Pharma US Inc
$76
Merck Sharp & Dohme LLC
$72
Ferring Pharmaceuticals Inc.
$65
UROGEN PHARMA, INC.
$46
Antares Pharma, Inc.
$32
ABBVIE INC.
$30
COLOPLAST CORP
$27
PROCEPT BioRobotics Corporation
$24
Laborie Medical Technologies Corp.
$23
Medtronic, Inc.
$22
PFIZER INC.
$20
Endo USA, Inc.
$20
DENTSPLY IH AB
$16
Myriad Genetic Laboratories, Inc.
$13
Top 3 companies account for 40.8% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$998
Sumitomo Pharma America, Inc.
$538
PFIZER INC.
$401
Axonics, Inc.
$357
Endo Pharmaceuticals Inc.
$303
TOLMAR Pharmaceuticals, Inc.
$244
Blue Earth Diagnostics Limited
$215
Medtronic USA, Inc.
$211
180 Medical, Inc.
$184
Medtronic, Inc.
$163
Antares Pharma, Inc.
$152
Merck Sharp & Dohme Corporation
$130
Allergan, Inc.
$125
Coloplast Corp
$102
Supernus Pharmaceuticals, Inc.
$99
Allergan Inc.
$88
Boston Scientific Corporation
$84
Dendreon Pharmaceuticals LLC
$80
Myriad Genetic Laboratories, Inc.
$75
Merck Sharp & Dohme LLC
$72
Ferring Pharmaceuticals Inc.
$65
Myovant Sciences Inc.
$53
Laborie Medical Technologies Corp.
$53
ABBVIE INC.
$48
UROGEN PHARMA, INC.
$46
NeoTract Inc.
$44
BOSTON SCIENTIFIC CORPORATION
$43
DENTSPLY IH Inc.
$43
Teleflex LLC
$41
COLOPLAST CORP
$40
Augmenix, Inc.
$36
C. R. Bard, Inc. & Subsidiaries
$34
Bayer HealthCare Pharmaceuticals Inc.
$32
UROVANT SCIENCES INC
$31
Acerus Pharmaceuticals Corporation
$25
Cook Medical LLC
$24
Janssen Biotech, Inc.
$24
PROCEPT BioRobotics Corporation
$24
Olympus America Inc.
$23
Endo USA, Inc.
$20
Agiliti Surgical, Inc.
$18
DENTSPLY IH AB
$16
Axonics Modulation Technologies, Inc.
$15
Alnylam Pharmaceuticals Inc.
$14
Eisai Inc.
$12
Aytu BioScience, Inc
$11
Top 3 companies account for 35.5% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AQUABEAM SYSTEM · ARIS · Aris · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · BRIDION · Bulkamid · Cook Medical Stents · Dayvigo · ELIGARD · EndoSheath Technology · GEMTESA · GENERAL BPH · GENTLECATH · General - Erectile Dysfunction · INTERSTIM · JELMYTO · KEYTRUDA · LOFRIC · LYNPARZA · LoFric · MYRBETRIQ · Myrbetriq · NCircle · NOCDURNA · Natesto · Nubeqa · ORGOVYX · OXLUMO · PROLARIS · PROVENGE · Prolaris · REZUM · ReTrace · SPEEDICATH · SpaceOAR · SpaceOAR VUE System - 10mL · TLANDO · TOVIAZ · UROLIFT · UroLift · VESICARE · XIAFLEX · XTANDI · XYOSTED · Xtandi · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
158
County median income
$95,296
Nearest hospital to ZIP centroid (approximate)
ASCENSION PROVIDENCE ROCHESTER HOSPITAL
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Greski is a clinical cardiology specialist, with above-average Medicare volume (top 29% in MI), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Greski experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Greski performed 552 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Greski receive payments from pharmaceutical companies?
Yes. Dr. Greski received a total of $5,458 from 46 companies across 277 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Greski's costs compare to other urology physicians in Rochester Hills?
Dr. Greski's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Greski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Rochester Hills
Browse urology physicians in Rochester Hills ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MI
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MI
Which MI urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology